Search

Your search keyword '"Bracamonte T"' showing total 7 results
Start Over Author "Bracamonte T" Search Limiters Available in Library Collection
7 results on '"Bracamonte T"'

1. Impact of Prematurity and Severe Viral Bronchiolitis on Asthma Development at 6–9 Years

Author

Garcia-Garcia ML, Gonzalez-Carrasco E, Bracamonte T, Molinero M, Pozo F, Casas I, and Calvo C

Subjects
asthma, wheezing, prematurity, bronchiolitis, rhinovirus, respiratory syncytial virus, Immunologic diseases. Allergy, RC581-607
Abstract

Maria Luz Garcia-Garcia,1 Ersilia Gonzalez-Carrasco,2 Teresa Bracamonte,1 Mar Molinero,3 Francisco Pozo,3 Inmaculada Casas,3 Cristina Calvo4 1Pediatrics Department, Severo Ochoa University Hospital, Fundación IDIPHISA, Alfonso X El Sabio University Madrid, Spain. Translational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain; 2Department, Severo Ochoa University Hospital, Fundación IDIPHISA. Alfonso X El Sabio University, Madrid, Spain; 3Respiratory Virus and Influenza Unit, National Microbiology Center (ISCIII), Madrid, Spain; 4Pediatric Infectious Diseases Department, Fundación IdiPaz, Translational Research Network in Pediatric Infectious Diseases (RITIP), Madrid, Spain. TEDDY Network (European Network of Excellence for Pediatric Clinical Research), Italy. La Paz University Hospital, Madrid, SpainCorrespondence: Maria Luz Garcia-Garcia Email marialuz.hso@gmail.comBackground: Premature birth is associated with increased susceptibility for viral infections and chronic airway morbidity. Preterm children, even moderate and late, may be at risk for short- and long-term respiratory morbidities.Objective: Our main goal was to compare the burden of two conditions, severe bronchiolitis and prematurity (early and moderate-late), on asthma development at 6– 9 years.Patients and Methods: A retrospective cohort of all preterm (< 37weeks gestational age) and full-term children hospitalized for bronchiolitis, with current age between 6 and 9 years, was created. A second cohort was made up of preterm children, without admission for bronchiolitis, randomly chosen from the hospital premature births database. Prevalence and risk factors for asthma were analysed. Parents completed the International Study of Asthma and Allergies in Childhood (ISAAC) Questionnaire for asthma symptoms for children 6– 7 years. Lung function and aeroallergen sensitization were evaluated.Results: Of the 480 selected children, 399 could be contacted and agreed to participate: 133 preterm and 114 full-term cases with admission for bronchiolitis and 146 preterm control children without admission for bronchiolitis. The frequency of current asthma at 6– 9 years was higher in preterm cases (27%) compared with full-term-cases (15%) and preterm controls (14%) (p=0.04). Among hospitalized-bronchiolitis children, prematurity (p=0.04), rhinovirus infection (p=0.03), viral coinfection (p=0.04) and paternal asthma (p=0.003) were risk factors for asthma at 6– 9 years. Among premature children, with and without bronchiolitis admission, the risk factors for asthma at 6– 9 years were admission for bronchiolitis (p=0.03) and aeroallergen sensitisation (p=0.01). Moderate and late preterm children without admission for bronchiolitis showed similar prevalence of current asthma than full-term ones, previously admitted for bronchiolitis.Conclusion: Preterm birth is an important early life risk factor for asthma in childhood. The addition of other risk factors, such as severe bronchiolitis, especially by rhinovirus or viral coinfections, are associated with even higher risk for subsequent asthma.Keywords: asthma, wheezing, prematurity, bronchiolitis, rhinovirus, respiratory syncytial virus

Published
2020

2. Oral immunotherapy for food allergy: A Spanish guideline. Egg and milk immunotherapy Spanish guide (ITEMS GUIDE). Part 2: Maintenance phase of cow milk (CM) and egg oral immunotherapy (OIT), special treatment dosing schedules. Models of dosing schedules of OIT with CM and EGG

Author

Martorell, A., Alonso, E., Echeverría, L., Escudero, C., García-Rodríguez, R., Blasco, C., Bone, J., Borja-Segade, J., Bracamonte, T., Claver, A., Corzo, J.L., De la Hoz, B., Del Olmo, R., Dominguez, O., Fuentes-Aparicio, V., Guallar, I., Larramona, H., Martín-Muñoz, F., Matheu, V., Michavila, A., Ojeda, I., Ojeda, P., Piquer, M., Poza, P., Reche, M., Río, P. Rodríguez del, Rodríguez, M., Ruano, F., Sánchez-García, S., Terrados, S., Valdesoiro, L., and Vazquez-Ortiz, M.

Published
2017
Full Text
View/download PDF

3. Oral immunotherapy for food allergy: A Spanish guideline. Immunotherapy egg and milk Spanish guide (items guide). Part I: Cow milk and egg oral immunotherapy: Introduction, methodology, rationale, current state, indications contraindications and oral immunotherapy build-up phase

Author

Martorell, A., Alonso, E., Echeverría, L., Escudero, C., García-Rodríguez, R., Blasco, C., Bone, J., Borja-Segade, J., Bracamonte, T., Claver, A., Corzo, J.L., De la Hoz, B., Del Olmo, R., Dominguez, O., Fuentes-Aparicio, V., Guallar, I., Larramona, H., Martín-Muñoz, F., Matheu, V., Michavila, A., Ojeda, I., Ojeda, P., Piquer, M., Poza, P., Reche, M., Rodríguez del Río, P., Rodríguez, M., Ruano, F., Sánchez-García, S., Terrados, S., Valdesoiro, L., and Vazquez-Ortiz, M.

Published
2017
Full Text
View/download PDF

5. Oral Immunotherapy for Food Allergy: A Spanish Guideline. Egg and Milk Immunotherapy Spanish Guide (ITEMS GUIDE). Part II: Maintenance Phase of Cow Milk (CM) and Egg Oral Immunotherapy (OIT), Special Treatment Dosing Schedules. Models of Dosing Schedules of OIT With CM and Egg

Author

Martorell A, Alonso E, Echeverría L, Escudero C, García-Rodríguez R, Blasco C, Bone J, Borja-Segade J, Bracamonte T, Claver A, Corzo JL, De la Hoz B, Del Olmo R, Domínguez O, Fuentes-Aparicio V, Guallar I, Larramona H, Martín-Muñoz F, Matheu V, Michavila A, Ojeda I, Ojeda P, Piquer-Gibert M, Poza P, Reche M, Rodríguez Del Río P, Rodríguez M, Ruano F, Sánchez-García S, Terrados S, Valdesoiro L, Vazquez-Ortiz M, and Expert panel selected from members of the Spanish Society of Pediatric Allergolo

Subjects
medicine.medical_specialty, Oral immunotherapy, Immunology, Administration, Oral, Milk allergy, Desensitization, Omalizumab, Specific oral tolerance induction, Scientific evidence, Cow milk, 03 medical and health sciences, 0302 clinical medicine, Dosing schedules, Food allergy, medicine, Animals, Humans, Immunology and Allergy, Egg Hypersensitivity, Sublingual immunotherapy, 030201 allergy, Egg allergy, business.industry, Disease Management, Guideline, Allergens, medicine.disease, 3. Good health, Biotechnology, 030228 respiratory system, Desensitization, Immunologic, Spain, Family medicine, Milk Hypersensitivity, business, Guide, Food Hypersensitivity
Abstract

Background and objective Cow milk and egg are the most frequent causes of food allergy in the first years of life. Oral immunotherapy (OIT) has been investigated as an alternative to avoidance diets. No clinical practice guidelines on the management of OIT with milk and egg are currently available. Objectives: To develop clinical guidelines for OIT based on available scientific evidence and the opinions of experts. Methods A review was made of studies published between 1984 and June 2016, doctoral theses published in Spain, summaries of communications at scientific meetings (SEAIC, SEICAP, EAACI, and AAAAI), and the consensus of opinion established by a group of experts from the scientific societies SEICAP and SEAIC. Results Recommendations were established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of adverse reactions. Conclusions Clinical practice guidelines based on the consensus reached between Spanish experts are presented for the management of OIT with milk and egg.

Published
2017

6. Oral Immunotherapy for Food Allergy: A Spanish Guideline. Immunotherapy Egg and Milk Spanish Guide (ITEMS Guide). Part I: Cow Milk and Egg Oral Immunotherapy: Introduction, Methodology, Rationale, Current State, Indications, Contraindications, and Oral Immunotherapy Build-up Phase

Author

Martorell A, Alonso E, Echeverría L, Escudero C, García-Rodríguez R, Blasco C, Bone J, Borja-Segade J, Bracamonte T, Claver A, Corzo JL, De la Hoz B, Del Olmo R, Domínguez O, Fuentes-Aparicio V, Guallar I, Larramona H, Martín-Muñoz F, Matheu V, Michavila A, Ojeda I, Ojeda P, Piquer-Gibert M, Poza P, Reche M, Rodríguez Del Río P, Rodríguez M, Ruano F, Sánchez-García S, Terrados S, Valdesoiro L, Vazquez-Ortiz M, and Expert panel selected from members of the Spanish Society of Pediatric Allergolo

Subjects
medicine.medical_specialty, Oral immunotherapy, Immunology, Administration, Oral, Milk allergy, Desensitization, Omalizumab, Specific oral tolerance induction, Scientific evidence, Cow milk, 03 medical and health sciences, 0302 clinical medicine, Food allergy, medicine, Humans, Immunology and Allergy, Egg Hypersensitivity, Sublingual immunotherapy, 030201 allergy, Egg allergy, business.industry, Guideline, Allergens, medicine.disease, 3. Good health, Clinical Practice, 030228 respiratory system, Desensitization, Immunologic, Spain, Family medicine, Practice Guidelines as Topic, Milk Hypersensitivity, business, Guide
Abstract

Background and objective Cow milk and egg are the most frequent causes of food allergy in the first years of life. Oral immunotherapy (OIT) has been investigated as an alternative to avoidance diets. No clinical practice guidelines on the management of OIT with milk and egg are currently available. Objectives: To develop clinical guidelines for OIT based on available scientific evidence and the opinions of experts. Methods A review was made of studies published between 1984 and June 2016, doctoral theses published in Spain, summaries of communications at scientific meetings (SEAIC, SEICAP, EAACI, and AAAAI), and the consensus of opinion established by a group of experts from the scientific societies SEICAP and SEAIC. Results Recommendations were established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of adverse reactions. Conclusions Clinical practice guidelines based on the consensus reached between Spanish experts are presented for the management of OIT with milk and egg.

Published
2017
Full Text
View/download PDF

7. Oral immunotherapy for food allergy: Spanish Guidelines Milk and Egg Immunotherapy Spanish Guide (ITEMS guide)

Author

Martorell, A., Alonso, E., Echeverría, L., Escudero, C., García-Rodríguez, R., Blasco, C., Bone, J., Borja-Segade, J., Bracamonte, T., Claver, A., Corzo, J.L., De la Hoz, B., Del Olmo, R., Dominguez, O., Fuentes-Aparicio, V., Guallar, I., Larramona, H., Martín-Muñoz, F., Matheu, V., Michavila, A., Ojeda, I., Ojeda, P., Piquer, M., Poza, P., Reche, M., Rodríguez del Río, P., Rodríguez, M., Ruano, F., Sánchez-García, S., Terrados, S., Valdesoiro, L., and Vazquez-Ortiz, M.

Abstract

Cow's milk and egg are the most frequent causes of food allergy in the first years of life. Treatments such as oral immunotherapy (OIT) have been investigated as an alternative to avoidance diets. No clinical practice guides on the management of OIT with milk and egg are currently available.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results